Table 1.
Basic characteristics of incident cancer cases in the UK Biobank cohort
| Gender (%) | Death (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Cancer type | Cases | Median follow-up time (months) | Male | Female | Agea (mean ± SD) | BMI (mean ± SD) | All-cause | Cancer-specific |
| Bladder cancer | 526 | 49.63 | 426 (80.99) | 100 (19.01) | 67.11 ± 5.61 | 28.25 ± 4.34 | 170 (32.32) | 113 (21.48) |
| Brain cancer | 397 | 8.83 | 246 (61.96) | 151 (38.04) | 64.24 ± 7.04 | 27.65 ± 4.76 | 354 (89.17) | 334 (84.13) |
| Breast cancer | 4350 | 62.13 | 0 (0) | 4350 (100) | 61.84 ± 7.78 | 27.46 ± 5.10 | 319 (7.33) | 233 (5.36) |
| Colorectal cancer | 2621 | 48.57 | 1555 (59.33) | 1066 (40.67) | 65.25 ± 6.53 | 27.94 ± 4.59 | 779 (29.72) | 569 (21.71) |
| Corpus Uteri | 698 | 57.58 | 0 (0) | 698 (100) | 64.17 ± 6.29 | 30.30 ± 6.95 | 105 (15.04) | 78 (11.17) |
| Esophagus cancer | 460 | 19.57 | 344 (74.78) | 116 (25.22) | 66.42 ± 5.81 | 28.63 ± 5.61 | 296 (64.35) | 255 (55.43) |
| Gastric cancer | 303 | 14.60 | 222 (73.27) | 81 (26.73) | 66.30 ± 6.63 | 28.68 ± 4.91 | 220 (72.61) | 141 (46.53) |
| Lung cancer | 1700 | 11.47 | 945 (55.59) | 755 (44.41) | 66.65 ± 5.99 | 27.46 ± 4.73 | 1,287 (75.71) | 1,113 (65.47) |
| Lymphoid Leukaemia | 350 | 51.90 | 209 (59.71) | 141 (40.29) | 65.42 ± 6.04 | 27.96 ± 5.11 | 58 (16.57) | 26 (7.43) |
| Multiple Myeloma | 355 | 43.10 | 207 (58.31) | 148 (41.69) | 65.86 ± 6.78 | 27.79 ± 4.54 | 122 (34.37) | 90 (25.35) |
| Oral and pharynx cancer | 458 | 50.45 | 312 (68.12) | 146 (31.88) | 62.80 ± 6.94 | 27.27 ± 4.92 | 120 (26.2) | 71 (15.5) |
| Ovarian cancer | 437 | 40.33 | 0 (0) | 437 (100) | 63.65 ± 7.26 | 27.29 ± 4.86 | 201 (46) | 177 (40.5) |
| Pancreatic cancer | 506 | 5.35 | 274 (54.15) | 232 (45.85) | 66.27 ± 6.29 | 28.21 ± 5.02 | 460 (90.91) | 422 (83.4) |
| Prostate cancer | 4882 | 57.93 | 4,882 (100) | 0 (0) | 66.77 ± 5.32 | 27.55 ± 3.83 | 460 (9.42) | 258 (5.28) |
| Renal cancer | 649 | 44.40 | 425 (65.49) | 224 (34.51) | 65.21 ± 6.38 | 29.18 ± 5.26 | 209 (32.2) | 147 (22.65) |
| Skin Melanoma | 1402 | 56.27 | 717 (51.14) | 685 (48.86) | 63.39 ± 7.68 | 27.58 ± 4.48 | 119 (8.49) | 79 (5.63) |
| Thyroid cancer | 179 | 60.27 | 57 (31.84) | 122 (68.16) | 62.06 ± 7.56 | 27.66 ± 4.70 | 16 (8.94) | 6 (3.35) |
aAge at diagnosis.
Note: BMI, body mass index.